AI-powered search
Try Polaris, our new AI-powered search!

How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation?

Featuring Cheri Frey, MD |

Assistant Professor, Dermatology & Residency Program Director 
Director of Cosmetic Dermatology
Howard University
Washington, DC

| Published June 01, 2024